RSS Feeds
Search

Companies

Companies

Displaying 1..9 of 9 - per page
Order by
Profiled on pharmalicensing.com APR Applied Pharma Research S.A.
APR is a private, independent, integrated Healhcare Company focused on Delivering, Funding and Supporting Innovation in Healthcare. More
Profiled on pharmalicensing.com Amarin Technologies S.A.
Amarin is engaged in the development of innovative pharmaceutical products using its proprietary topical and transdermal drug delivery technologies and know-how. More
Jelfa Pharmaceutical Company
Production, distribution and marketing of solid, semi-solid and injectable preparations. More
ALTANA Pharma
The Brazilian affiliate of ALTANA Pharma AG More
BTG
BTG is an international specialty pharmaceuticals company that is developing and commercialising products targeting critical care, cancer, neurological and other disorders. More
Helsinn Healthcare
Integrated licensing is our core business More
ForTe BV
Formulation Technology & Consultancy for Pharma, Food & Cosmetics More
Scil Biomedicals
Scil Biomedicals business objective is to develop and market innovative, protein-based biopharmaceuticals and medical devices. More
MedSource
MedSource is a niche CRO focused on the Project Management and Monitoring of critical Phase I-IV studies in difficult therapeutics like Oncology, HIV, and Infectious disease. More
Displaying 1..9 of 9 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
National Institute of Arthritis and Musculoskeletal and Skin Diseases – Developmental Therapeutics Review – Q4 2010
Nov 2010 - 40 pages - $500
National Institute of Arthritis and Musculoskeletal and Skin Diseases – Developmental Therapeutics Review – Q4 2010
Dec 2010 - 84 pages - $500
Musculoskeletal Disorders Pipeline Databook - November 2011
Nov 2011 - 7 pages - $3,835
Musculoskeletal Pain Global Clinical Trials Review, Q1, 2011
Mar 2011 - 34 pages - $1,000
Musculoskeletal Transplant Foundation - Medical Equipment - Deals and Alliances Profile
Mar 2011 - 16 pages - $250
Deals and alliances in musculoskeletal diseases
Jun 2006 - 378 pages - $2,495
Musculoskeletal Pain - Pipeline Review, H2 2011
Oct 2011 - 134 pages - $500
Musculoskeletal Pain - Pipeline Review, Q1 2011
Mar 2011 - 82 pages - $500
New Drug Futures 2009
Apr 2009 - 450 pages - $3,490
Musculoskeletal Disorders Therapeutics to 2016 - Introduction of Monoclonal Antibodies with First - in - class Mechanism of Action to Increase Treatment Options in Osteoporosis and Rheumatoid Arthritis
Oct 2010 - 169 pages - $3,500
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us